GlassScriptPhysician profile
Randall C Perkins
NPI 1487691424
$568.48
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $62.02 · 2021: $79.33 · 2022: $14.02.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $268.51 | 2019-2022 | |
| Astellas Pharma US INC | $53.90 | 2019-2021 | |
| Pfizer INC. | $53.11 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $47.86 | 2019 | |
| Glaxosmithkline, LLC. | $45.30 | 2019-2020 | |
| Amgen INC. | $36.67 | 2019 | |
| Amarin Pharma, INC. | $24.71 | 2019 | |
| Abbott Laboratories | $22.88 | 2019 | |
| Si-Bone, INC. | $15.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.